Track papers across labs, topics, and trends.
Search papers, labs, and topics across Lattice.
To address extreme long-tail bias and diagnostic hallucinations in clinical LLMs, RareDx pairs controlled evidence routing with knowledge-graph-grounded policy optimization (RareDx-KGPO). The system scores diagnostic candidates by projecting outputs into a canonical disease graph using rewards derived from ontology proximity, biomedical similarity, phenotype consistency, and strict output-budget constraints. Operating on Qwen3.5-9B, RareDx reaches 38.34 macro Hit@10 across eight benchmarks, outperforming GPT-5.5 by 1.6 points while scaling to 40.76 Hit@10 with a 27B parameter backbone.
Grounding policy optimization in canonical disease graphs allows a compact 9B model to outperform GPT-5.5 on long-tail clinical diagnosis, revealing that controlled evidence routing matters far more than raw retrieval volume.
Rare-disease diagnosis is a long-tail reasoning problem: phenotypes are incomplete, individual disorders are sparsely documented, and relevant evidence is distributed across ontologies, gene annotations, and biomedical text. Language models consequently favor common conditions, miss rare candidates, or produce plausible but invalid names. We introduce RareDx, which couples controlled evidence use with knowledge-graph-grounded policy optimization. RareDx-Harness normalizes heterogeneous records into one ranked-diagnosis task and compares direct inference, static retrieval, adaptive tools, and structured phenotype-gene-disease reasoning over a shared knowledge layer. The training pipeline combines Top-10 post-training with RareDx-KGPO, our knowledge-graph-grounded policy optimization method. Its reward projects predictions into a canonical disease graph and integrates curated graded relevance, ontology proximity, biomedical similarity, and phenotype consistency. Vocabulary and output-budget constraints prevent dense partial credit from rewarding fabricated or overlong differentials. Across eight benchmarks, the complete RareDx system centered on Qwen3.5-9B reaches 38.34 macro Hit@10, 1.60 points above GPT-5.5 under the archived protocol; a disjoint validation-selection audit retains a 6.80-point routing gain over Direct on held-out cases. The 27B system reaches 23.53/36.56/40.76 at Hit@1/5/10. Controlled ablations show that retrieval is not uniformly helpful and that controlled routing is central to the gain. These results indicate that structured medical knowledge can turn a compact model into a competitive diagnostic ranker across heterogeneous long-tail settings in clinical practice.